Recent studies indicate that inflammatory cues from myeloid cells to cardiac fibroblasts are critical to cardiac remodeling and function, with interleukin 1 (IL-1) signaling blockade mitigating fibrosis and heart failure in preclinical models3,4 and having promising effects on cardiovascular endpoints and heart failure in humans5. The gene discussed is IL1B; the disease is heart failure.